Linking physics in two‐year colleges and physics professional societies

Objectives: To assess shared decision-making (SDM) knowledge, attitude and application among health professionals involved in breast cancer (BC) treatment. Materials and Methods: A cross-sectional study based on an online questionnaire, sent by several professional societies to health professionals involved in BC management. There were 26 questions which combined demographic and professional data with some items measured on a Likert-type scale. Results: The participation (459/541; 84.84%) and completion (443/459; 96.51%) rates were high. Participants strongly agreed or agreed in 69.57% (16/23) of their responses. The majority stated that they knew of SDM (mean 4.43 (4.36–4.55)) and were in favour of its implementation (mean 4.58 (4.51–4.64)). They highlighted that SDM practice was not adequate due to lack of resources (3.46 (3.37–3.55)) and agreed on policies that improved its implementation (3.96 (3.88–4.04)). The main advantage of SDM for participants was patient satisfaction (38%), and the main disadvantage was the patients’ paucity of knowledge to understand their disease (24%). The main obstacle indicated was the lack of time and resources (40%). Conclusions: New policies must be designed for adequate training of professionals in integrating SDM in clinical practice, preparing them to use SDM with adequate resources and time provided.

Download Full-text

Comprehensive Review of Knee Osteoarthritis Pharmacological Treatment and the Latest Professional Societies’ Guidelines

Pharmaceuticals ◽

10.3390/ph14030205 ◽

2021 ◽

Vol 14 (3) ◽

pp. 205

Author(s):

Dragan Primorac ◽

Vilim Molnar ◽

Vid Matišić ◽

Damir Hudetz ◽

Željko Jeleč ◽

...

Keyword(s):

Knee Osteoarthritis ◽

Platelet Rich Plasma ◽

Symptom Relief ◽

Topical Administration ◽

Symptomatic Therapy ◽

Therapy Options ◽

Professional Societies ◽

Inflammatory Drugs ◽

The Right

Osteoarthritis is the most common musculoskeletal progressive disease, with the knee as the most commonly affected joint in the human body. While several new medications are still under research, many symptomatic therapy options, such as analgesics (opioid and non-opioid), nonsteroid anti-inflammatory drugs, symptomatic slow-acting drugs in osteoarthritis, and preparations for topical administration, are being used, with a diverse clinical response and inconsistent conclusions across various professional societies guidelines. The concept of pharmacogenomic-guided therapy, which lies on principles of the right medication for the right patient in the right dose at the right time, can significantly increase the patient’s response to symptom relief therapy in knee osteoarthritis. Corticosteroid intra-articular injections and hyaluronic acid injections provoke numerous discussions and disagreements among different guidelines, even though they are currently used in daily clinical practice. Biological options, such as platelet-rich plasma and mesenchymal stem cell injections, have shown good results in the treatment of osteoarthritis symptoms, greatly increasing the patient’s quality of life, especially when combined with other therapeutic options. Non-inclusion of the latter therapies in the guidelines, and their inconsistent stance on numerous therapy options, requires larger and well-designed studies to examine the true effects of these therapies and update the existing guidelines.

Download Full-text

Towards personalised management for non-variceal upper gastrointestinal bleeding

Gut ◽

10.1136/gutjnl-2020-323846 ◽

2021 ◽

pp. gutjnl-2020-323846

Author(s):

Joseph J Y Sung ◽

Loren Laine ◽

Ernst J Kuipers ◽

Alan N Barkun

Keyword(s):

Gastrointestinal Bleeding ◽

Upper Gastrointestinal Bleeding ◽

Point Of Care ◽

Management Strategies ◽

Patient Characteristics ◽

Professional Societies ◽

Assessment And Treatment ◽

Three Stages ◽

Endoscopic Assessment ◽

Upper Gastrointestinal

Guidelines from national and international professional societies on upper gastrointestinal bleeding highlight the important clinical issues but do not always identify specific management strategies pertaining to individual patients. Optimal treatment should consider the personal needs of an individual patient and the pertinent resources and experience available at the point of care. This article integrates international guidelines and consensus into three stages of management: pre-endoscopic assessment and treatment, endoscopic evaluation and haemostasis and postendoscopic management. We emphasise the need for personalised management strategies based on patient characteristics, nature of bleeding lesions and the clinical setting including available resources.

Download Full-text

Occupational Programs in Texas Two-Year Colleges and Proprietary Schools

Community College Review ◽

10.1177/009155218401200207 ◽

1984 ◽

Vol 12 (2) ◽

pp. 37-40 ◽

Cited By ~ 1

Author(s):

R. C. Fournet

Keyword(s):

Proprietary Schools ◽

Two Year Colleges ◽

Occupational Programs

Download Full-text

Call for action to healthcare professional societies and other groups: Creating a global open access E-learning knowledge platform for Antimicrobial Stewardship [AMS] with a focus on LMIC's

Indian Journal of Medical Microbiology ◽

10.1016/j.ijmmb.2021.03.020 ◽

2021 ◽

Author(s):

Dilip Nathwani

Keyword(s):

Open Access ◽

Healthcare Professional ◽

Antimicrobial Stewardship ◽

Professional Societies ◽

Knowledge Platform ◽

E Learning

Download Full-text

Transiently increased risk of breast cancer after childbirth: implications for fertility treatments and surrogacy

Human Reproduction ◽

10.1093/humrep/deaa102 ◽

2020 ◽

Vol 35 (6) ◽

pp. 1253-1255

Author(s):

Zeev Blumenfeld ◽

Norbert Gleicher ◽

Eli Y Adashi

Keyword(s):

Breast Cancer ◽

Breast Cancer Risk ◽

Cancer Risk ◽

Meta Analysis ◽

Small Degree ◽

Short Term ◽

Benefit Ratio ◽

Professional Societies ◽

Fertility Treatments ◽

Increased Risk

Abstract Whereas longstanding dogma has purported that pregnancies protect women from breast cancer, a recent meta-analysis now mandates reconsideration since it reported an actual higher breast cancer risk for more than two decades after childbirth before the relative risk turns negative. Moreover, the risk of breast cancer appears higher for women having their first birth at an older age and with a family history and it is not reduced by breastfeeding. The process of obtaining informed consent for all fertility treatments, therefore, must make patients aware of the facts that every pregnancy, to a small degree, will increase the short-term breast cancer risk. This observation may be even more relevant in cases of surrogacy where women agree to conceive without deriving benefits of offspring from assuming the risk, thus creating a substantially different risk-benefit ratio. Consequently, it appears prudent for professional societies in the field to update recommendations regarding consent information for all fertility treatments but especially for treatments involving surrogacy.

Download Full-text